Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

31 results about "Hexon protein" patented technology

In molecular biology, the hexon protein is a major coat protein found in Adenoviruses. Hexon coat proteins are synthesised during late infection and form homo-trimers. The 240 copies of the hexon trimer that are produced are organised so that 12 lie on each of the 20 facets. The central 9 hexons in a facet are cemented together by 12 copies of polypeptide IX. The penton complex, formed by the peripentonal hexons and penton base (holding in place a fibre), lie at each of the 12 vertices. The hexon coat protein is a duplication consisting of two domains with a similar fold packed together like the nucleoplasmin subunits. Within a hexon trimer, the domains are arranged around a pseudo 6-fold axis. The domains have a beta-sandwich structure consisting of 8 strands in two sheets with a jelly-roll topology; each domain is heavily decorated with many insertions. Some hexon proteins contain a distinct C-terminal domain.

Anti-human adenovirus antibody, and preparation method therefor and use thereof

An anti-human adenovirus (AdV) antibody, a preparation method, a kit comprising the antibody, and the related use thereof. The anti-human adenovirus antibody can specifically bind hexon proteins of various types of adenoviruses, shows high sensitivity and high specificity for adenoviruses, can be used for detecting various types of adenoviruses, greatly increases the detection rate of adenoviruses, reduces the detection cost, and provides a feasible scheme for rapid detection of adenoviruses in the respiratory tract and the digestive tract.
Owner:ZHUHAI HEAVYBIO CO LTD

A combination and application of monoclonal antibodies for specific detection of adenovirus type 5

The present invention belongs to the field of virus detection technology, and specifically relates to a combination and application of monoclonal antibodies for the specific detection of type 5 adenovirus. The antibody combination includes 8B9 and 4A6, which target different epitopes of the HADV‑5 Hexon protein, respectively, and are suitable for a double-antibody sandwich ELISA detection system. Among them, 8B9 is used as a coating antibody, and 4A6 is used as an HRP-labeled detection antibody. The combination of the two can achieve high sensitivity and high specificity detection of HADV‑5 and replication-deficient recombinant type 5 adenovirus, and does not cross-react with other common adenovirus types. The present invention also provides the variable region amino acid sequence and nucleotide sequence of the above-mentioned antibody, as well as an ELISA detection method based on the antibody combination. The method is simple to operate, has good repeatability, and is suitable for the detection of type 5 adenovirus.
Owner:BEIJING SUBENYUANHE BIOTECHNOLOGY CO LTD

Hybridoma cell strain for recognizing 188th amino acid of highly pathogenic serum type 4 fowl adenovirus Hexon protein, monoclonal antibody and application of hybridoma cell strain

The invention discloses a hybridoma cell strain capable of recognizing 188th amino acid of a highly pathogenic serum type 4 fowl adenovirus Hexon protein, a monoclonal antibody and application of the hybridoma cell strain. The preservation number of the cell strain 2C5 is CGMCC NO.45829, and the monoclonal antibody 2C5 capable of specifically recognizing the highly pathogenic serum type 4 fowl adenovirus hexon Hexon protein is secreted. The amino acid sequence of the antigen epitope recognized by the gene is Hexon protein GPGRNP, wherein the R188 amino acid in the Hexon protein is the key amino acid recognized by the gene. The monoclonal antibody 2C5 prepared by the invention has the specificity of high-pathogenicity FAdV-4, can specifically recognize the high-pathogenicity FAdV-4, has no cross reaction with non-pathogenicity FAdV-4 and FAdV-4 of other serotypes, and can be used as a diagnostic reagent for distinguishing the high-pathogenicity FAdV-4 and the non-pathogenicity FAdV-4.
Owner:YANGZHOU UNIV

Human adenovirus multi-serotype Hexon chimeric antigen as well as preparation method and application thereof

PendingCN119060205AOvercome shortcomings such as difficultygood antigenicityBacteriaMicroorganism based processesEpitopeSerotype
The invention relates to a human adenovirus multi-serotype Hexon chimeric antigen, which is formed by connecting dominant epitope regions of conserved regions of Hexon proteins of type 3, type 7 and type 55 and specific dominant epitope regions of hypervariable regions in series, and dominant epitopes of the Hexon proteins of type 3 comprise 39-81aa and 103-258aa fragments; the dominant epitope of the type 7 Hexon protein comprises a fragment 153 to 255aa; the dominant epitope of the type 55 Hexon protein comprises a 175-319aa fragment. The invention also relates to a preparation method and application of the antigen. According to the invention, Hexon advantage and specific antigen fragments of several main subtypes infected by domestic human adenovirus are selected, dominant epitope regions of conserved regions of various subtypes are combined, the human adenovirus antigen with strong antigenicity and high positive detection rate is prepared by chimeric expression of the Hexon advantage and specific antigen fragments, and the human adenovirus antigen is used as a diagnosis antigen of a human adenovirus antibody to be applied to a detection kit.
Owner:QINGDAO HIGHTOP BIOTECH

Diagnostic kit based on pigeon adenovirus Hexon protein and application

The invention discloses an anti-pigeon adenovirus Hexon protein monoclonal antibody, the anti-pigeon adenovirus Hexon protein monoclonal antibody is a monoclonal antibody 1H5-8-14-5, and amino acid sequences of a heavy chain variable region and a light chain variable region of the monoclonal antibody 1H5-8-14-5 are respectively as shown in SEQ ID NO.3 and SEQ ID NO.4. The invention further discloses a preparation method of the anti-pigeon adenovirus Hexon protein monoclonal antibody. The invention also discloses a double-antibody sandwich ELISA diagnostic kit for detecting the pigeon adenovirus antigen. The kit comprises an elisa plate coated with an anti-Hexon protein polyclonal antibody, Hexon protein, an HRP labeled anti-pigeon adenovirus Hexon protein monoclonal antibody, a negative control, a developing solution, a washing solution and a stop solution. The kit disclosed by the invention can effectively detect the pigeon adenovirus, provides a new technical means for prevention and control of the pigeon adenovirus, is accurate in detection result and high in specificity, and has a relatively good application value.
Owner:ZHEJIANG SCI-TECH UNIV +2

Canine adenovirus type 2 hexon protein specific antibody and application thereof

The invention discloses a canine adenovirus type 2 hexon protein specific antibody and application thereof, and belongs to the field of pet epidemic disease detection. The specific antibody is a monoclonal antibody and contains a heavy chain variable region and a light chain variable region, each of the heavy chain variable region and the light chain variable region is composed of a complementary determining region and a frame region, the heavy chain complementary determining region is composed of CDR1, CDR2 and CDR3, and the light chain complementary determining region is composed of CDR1 and CDR2. The specific antibody can be used for preparing canine adenovirus detection products. The canine adenovirus enzyme-linked immunosorbent assay kit provided by the invention has the characteristics of high sensitivity, good specificity and strong stability.
Owner:北京纳百生物科技有限公司

Anti-human type 4 adenovirus specific nano antibody LUM44 and application thereof in antiviral therapy

The present invention relates to a nanobody against human adenovirus type 4 Hexon protein, which nanobody has a unique CDR region, can bind to adenovirus type 4 Hexon protein with high affinity, and can neutralize adenovirus type 4 pseudovirus with high neutralizing activity in a virus neutralization test, and to the use thereof in antiviral therapy. The invention also provides application of the nano antibody in preparation of a medicine for treating and / or preventing human type 4 adenovirus infectious diseases and a diagnostic kit.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Natural human monoclonal antibody B1AG for resisting human type 4 adenovirus Hexon protein and application of natural human monoclonal antibody B1AG

The invention provides a human monoclonal antibody B1AG for resisting type 4 adenovirus. The neutralizing antibody for resisting the 4-type adenovirus provided by the invention can be specifically combined with the 4-type adenovirus, and has very high affinity activity and very strong neutralizing activity at low concentration. The invention also provides application of the antibody in preparation of medicines for treating and / or preventing type 4 adenovirus diseases, and a detection kit containing the antibody.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Nanometer antibody CTR96 targeting human type 4 adenovirus Hexon protein and application

The present invention relates to an anti-human adenovirus type 4 Hexon protein nanobody and an application thereof, the nanobody having a unique CDR region, capable of binding to the adenovirus type 4 Hexon protein with high affinity, and capable of neutralizing adenovirus type 4 pseudovirus with high neutralizing activity in a virus neutralization test. The invention also provides application of the nano antibody in preparation of a medicine for treating and / or preventing human type 4 adenovirus infectious diseases and a diagnostic kit.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Recombinant adenoviruses displaying ultra-large fragment antigens on their capsid surface: construction methods and applications

This invention relates to the field of bioengineering technology, specifically to a recombinant adenovirus displaying a large antigen fragment on its capsid surface, its construction method, and its applications. The HVR1 and HVR5 regions of the hexon hypervariable region of this virus are replaced by gene fragments containing exogenous genes; each exogenous gene fragment has a flexible linker attached to both ends, and the gene sequence of the flexible linker is shown in SEQ ID No. 1. By precisely locating the naturally variable HVR1 and HVR5 loop regions exposed on the surface of the hexon protein as insertion sites, and supplementing them with flexible linkers, the core problem of exogenous sequence insertion disrupting the stability of the hexon structure is successfully solved. This allows for stable packaging to produce viral particles with high titers and infectivity, enabling the development of a new generation of highly efficient and safe capsid-displaying adenovirus vaccines.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Hexameric protein-based method for screening of natural product antiviral drugs and use thereof

The application discloses a kind of natural product antiviral drug screening method based on hexagon protein and application, belong to active ingredient screening and antiviral drug development field.The method includes: preparation nitrogen-doped mesoporous carbon and silver nanosheet composite solution, drop coating on the surface of pretreated glassy carbon electrode, after drying by activation, hexagon protein incubation, blocking and enzyme label antibody reaction, construct electrochemical sensing electrode;With the electrode, the sample to be screened natural product is incubated, and the current response signal is detected;According to signal change combination inhibition rate formula evaluation antiviral activity.The application takes hexagon protein as recognition target, based on the principle of competitive immunoassay, realizes the specific, high sensitivity detection of antiviral active ingredient in natural product, with the advantages of fast operation, low cost, small sample consumption, high throughput, etc., provides effective technical support for the mining of antiviral active ingredient in natural product such as traditional Chinese medicine.
Owner:GANSU SECOND PEOPLES HOSPITAL +1

A diagnostic kit based on pigeon adenovirus Hexon protein and its application

The present invention discloses an anti-pigeon adenovirus Hexon protein monoclonal antibody, the anti-pigeon adenovirus Hexon protein monoclonal antibody is monoclonal antibody 1H5-8-14-5, wherein the amino acid sequences of the heavy chain variable region and the light chain variable region of monoclonal antibody 1H5-8-14-5 are shown in SEQ ID NO.3 and SEQ ID NO.4, respectively. The present invention also discloses a double antibody sandwich ELISA diagnostic kit for detecting pigeon adenovirus antigens, the kit comprising an enzyme labeling plate coated with an anti-Hexon protein polyclonal antibody, Hexon protein, HRP-labeled anti-pigeon adenovirus Hexon protein monoclonal antibody, a negative control, a color developing solution, a washing solution, and a stop solution. The kit of the present invention can effectively detect pigeon adenovirus, provides a new technical means for pigeon adenovirus prevention and control, and the detection result is accurate and specific, with good application value.
Owner:ZHEJIANG SCI-TECH UNIV +2

Anti-human adenovirus type 4 specific nanoantibody LUM44 and its application in antiviral therapy

The present invention relates to a nanobody directed against the human adenovirus type 4 Hexon protein and its use in antiviral therapy. The nanobody has a unique CDR region, can bind to the adenovirus type 4 Hexon protein with high affinity, and can neutralize adenovirus type 4 pseudovirus with high neutralizing activity in virus neutralization assays. The present invention also provides the use of the nanobody in the preparation of a drug for treating and / or preventing diseases caused by human adenovirus type 4, as well as a diagnostic kit.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Adenovirus comprising a modified adenovirus hexon protein

The invention discloses a human adenovirus species C having a capsid which comprises a modified adenovirus hexon protein, wherein the modified adenovirus hexon protein has a modified HVR1 region, wherein the modified HVR1 region has the sequence DEAATALEINLKKKKQAEQQ (SEQ ID NO.: 1). The invention further discloses the adenovirus of the disclosure for use in treating or preventing a human disease. The invention further discloses a nucleic acid encoding the modified adenovirus hexon protein. The invention further discloses the use of an adenovirus according to the disclosure for transducing mesenchymal stromal cells (MSCs) or tumor cells. The invention further discloses an in vitro method for transducing MSCs and a transduced MSC obtainable by the method. The invention further discloses the transduced MSC of the disclosure for use in treating a disease.
Owner:UNIV ULM

Recombinant lactic acid bacteria expressing truncated hexon protein of avian adenovirus, construction method and application thereof

PendingCN122357414AStaphylococcus lactisAvian adenovirus
This invention discloses a recombinant lactic acid bacteria expressing a truncated avian adenovirus Hexon protein, its construction method, and its applications, belonging to the field of biomedical technology. This invention is the first to construct recombinant lactic acid bacteria strains pNZ8149-FAdV4ΔHexon / NZ3900 and pNZ8149-FAdV8bΔHexon / NZ3900 expressing the truncated avian adenovirus Hexon protein. SDS-PAGE and Western blotting analyses showed that the exogenous genes FADV4-ΔHexon and FADV-8bΔHexon were successfully expressed in *Lactococcus lactis* and exhibited reactivity. Oral immunization of one-day-old chicks showed that oral administration of the recombinant lactic acid bacteria induced humoral and cellular immunity, as well as local mucosal immunity. The results indicate that the recombinant constitutive lactic acid bacteria prepared in this invention can enhance the immunity of chicks.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Neutralizing nano-antibody AUR39 for resisting human adenovirus type 4 Hexon protein and application of neutralizing nano-antibody AUR39

The present invention relates to an anti-human adenovirus type 4 Hexon protein nanobody and an application thereof, the nanobody having a unique CDR region, capable of binding to the adenovirus type 4 Hexon protein with high affinity, and capable of neutralizing adenovirus type 4 pseudovirus with high neutralizing activity in a virus neutralization test. The invention also provides application of the nano antibody in preparation of a medicine for treating and / or preventing human type 4 adenovirus infectious diseases and a diagnostic kit.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

An antibody against human adenovirus hexon protein and application thereof

This application relates to the field of biomedical technology, providing an antibody against human adenovirus hexon protein and its application. The antibody comprises a heavy chain variable region and a light chain variable region; wherein the heavy chain variable region comprises three heavy chain antigen complementary regions: amino acid sequences as shown in SEQ ID NO. 10-12; the light chain variable region comprises three light chain antigen complementary regions: LCDR1 with an amino acid sequence as shown in SEQ ID NO. 13, LCDR2 with an amino acid sequence of AAS, and LCDR3 with an amino acid sequence as shown in SEQ ID NO. 14. Related experiments have confirmed that this antibody can specifically recognize human adenovirus type 55 (HAdV) Hexon protein, with the antigenic epitope in the A180-A193 region, and can effectively prevent and control infection by HAdV-55 and / or HAdV-11 viruses.
Owner:NANJING MEDICAL UNIV

A canine triple antibody chromatography test strip and preparation method thereof

The present application relates to the field of biological detection technology, and specifically discloses a canine triple antibody chromatography test strip and a preparation method thereof. The canine triple antibody chromatography test strip provided by the present application includes a PVC base plate; a sample pad, a conjugation pad, a nitrocellulose membrane and a water-absorbing pad are arranged on the PVC base plate; a detection T line and a quality control C line are arranged on the nitrocellulose membrane; the conjugation pad contains a canine distemper virus H protein probe marked with 525nm wavelength quantum dots, a canine parvovirus VP2 protein probe marked with 565nm wavelength quantum dots, and a canine infectious hepatitis virus hexon protein probe marked with 610nm wavelength quantum dots. The canine triple antibody chromatography test strip provided by the present application determines the positive and negative nature of the sample to be tested by detecting the fluorescence value emitted by the quantum dots. The test results are not subject to the subjective influence of the tester, and the test results are highly accurate and repeatable.
Owner:BEIJING JINNUO BAITAI BIOTECHNOLOGY CO LTD

Monoclonal antibody combination for specific detection of type-5 adenovirus and application of monoclonal antibody combination

The invention belongs to the technical field of virus detection, and particularly relates to a composition for specific detection of a monoclonal antibody for type-5 adenovirus and application of the composition. The antibody combination comprises 8B9 and 4A6 which respectively target different epitopes of HADV-5 Hexon protein, and is suitable for a double-antibody sandwich ELISA (enzyme-linked immuno sorbent assay) detection system. Wherein 8B9 is used as a coating antibody, 4A6 is used as a detection antibody marked by HRP, high-sensitivity and high-specificity detection of HADV-5 and replication-deficient recombinant adenovirus 5 can be realized through cooperation of 8B9 and 4A6, and cross reaction with other common adenovirus types is avoided. The invention also provides a variable region amino acid sequence and a nucleotide sequence of the antibody, and an ELISA detection method based on the antibody combination. The method is simple and convenient to operate, good in repeatability and suitable for detecting the type 5 adenovirus.
Owner:BEIJING SUBENYUANHE BIOTECHNOLOGY CO LTD

Fowl adenovirus I group 4 type, 8a type and 8b type trivalent subunit vaccine as well as preparation method and application of fowl adenovirus I group 4 type, 8a type and 8b type trivalent subunit vaccine

The invention belongs to the technical field of biological medicines, discloses a fowl adenovirus I group 4 type, 8a type and 8b type trivalent subunit vaccine as well as a preparation method and application thereof, and provides an antigen composition prepared from a Fiber2 protein of FAdV-4, a Hexon protein of FAdV-8a and a Hexon protein of FAdV-8b in combination with a molecular adjuvant (such as Ch-IFN-gamma). The antigen composition is combined with an adjuvant to prepare the trivalent subunit vaccine. The vaccine has the advantages of high safety, comprehensive immune protection, easiness in large-scale production and the like, breaks through the technical bottleneck of the traditional inactivated vaccine, and provides a new tool for prevention and control of the fowl adenovirus disease.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Recombinant virus-like particle capsid vaccines against adenoviruses and compositions, methods, and use thereof

The present application relates to adenovirus virus-like particles (AdVLPs) and related compositions, plasmids, and methods. The AdVLP can include a recombinant capsid that comprises major capsid adenovirus (AdV) proteins such as a hexon protein, a penton protein, and a fiber protein, and minor capsid / cement AdV proteins, such as a Illa protein, a VI protein, a VIII protein, and a IX protein. The minor capsid / cement AdV proteins structurally support the major capsid AdV proteins. The recombinant capsid of the AdVLP can further include a chaperone AdV protein, and an accessory scaffold AdV protein.
Owner:UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SEC OF THE ARMY +1

Adenovirus comprising a modified adenovirus hexon protein

The invention discloses a human adenovirus species C having a capsid which comprises a modified adenovirus hexon protein, wherein the modified adenovirus hexon protein has a modified HVR1 region, wherein the modified HVR1 region has the sequence DEAATALEINLKKKKQAEQQ (SEQ ID NO.: 1). The invention further discloses the adenovirus of the disclosure for use in treating or preventing a human disease. The invention further discloses a nucleic acid encoding the modified adenovirus hexon protein. The invention further discloses the use of an adenovirus according to the disclosure for transducing mesenchymal stromal cells (MSCs) or tumor cells. The invention further discloses an in vitro method for transducing MSCs and a transduced MSC obtainable by the method. The invention further discloses the transduced MSC of the disclosure for use in treating a disease.
Owner:UNIV ULM

Neutralizing nanoantibody AUR39 against human adenovirus type 4 Hexon protein and its application

The present invention relates to a nanobody directed against the human adenovirus type 4 Hexon protein and its use. The nanobody has a unique CDR region, can bind to the adenovirus type 4 Hexon protein with high affinity, and can neutralize adenovirus type 4 pseudovirus with high neutralizing activity in virus neutralization tests. The present invention also provides the use of the nanobody in the preparation of a drug for treating and / or preventing diseases caused by human adenovirus type 4, as well as a diagnostic kit.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Hybridoma cell strain secreting anti-FAdV-4 Hexon protein monoclonal antibody, monoclonal antibody and application of monoclonal antibody

The invention discloses a hybridoma cell strain capable of secreting anti-FAdV-4Hexon protein, a monoclonal antibody and application of the hybridoma cell strain. The preservation number of the cell strain 6F11 is CGMCC NO.45830, and the cell strain 6F11 secretes the monoclonal antibody 6F11 which can be specifically combined with an antigen of the FAdV-4Hexon protein and does not have antigen-antibody reaction with other serotype FAdV-4Hexon protein. Through identification, the heavy chain subtype of the monoclonal antibody 6F11 is IgG1, the amino acid sequence of the antigen epitope identified by the monoclonal antibody 6F11 is 161TSTSKDT167, S162 and D166 are key amino acids identified by the monoclonal antibody 6F11, and the monoclonal antibody 6F11 can be used as a diagnostic reagent for distinguishing FAdV-4 and FAdV of other serotypes.
Owner:YANGZHOU UNIV

Recombinant adenovirus with oversized fragment antigen displayed on capsid surface, construction method and application

The invention relates to the technical field of bioengineering, in particular to the technical field of bioengineering, and particularly relates to a recombinant adenovirus with a capsid surface displaying an oversized fragment antigen, a construction method and application. An HVR1 region and an HVR5 region of a Hexon hypervariable region of the virus are respectively replaced by gene segments containing exogenous genes; in the gene segment, the two ends of the exogenous gene are respectively connected with a flexible connection segment, and the gene sequence of the flexible connection segment is as shown in SEQ ID No.1. HVR1 and HVR5 ring regions which are accurately positioned to be exposed on the surface of Hexon protein and have natural variability are used as insertion sites, and a flexible connecting fragment is supplemented, so that the core problem that the stability of a Hexon structure is damaged by insertion of an exogenous sequence is successfully solved, and virus particles with high titer and infection activity can be stably packaged and produced; a new generation of efficient and safe capsid display type adenovirus vaccine can be developed.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Nanobody CTR96 targeting human adenovirus type 4 Hexon protein and its application

The present invention relates to a nanobody directed against the human adenovirus type 4 Hexon protein and its use. The nanobody has a unique CDR region, can bind to the adenovirus type 4 Hexon protein with high affinity, and can neutralize adenovirus type 4 pseudovirus with high neutralizing activity in virus neutralization tests. The present invention also provides the use of the nanobody in the preparation of a drug for treating and / or preventing diseases caused by human adenovirus type 4, as well as a diagnostic kit.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Monoclonal antibody based on chimpanzee adenovirus type 68 and methods of making and uses thereof

ActiveCN116496388BAntigenProtein.monoclonal
The application discloses a hybridoma cell secreting a monoclonal antibody against Hexon protein of AdC68 obtained by immunizing mice with chimpanzee 68 type adenovirus hexon protein as an antigen, and corresponding sequences are obtained by sequencing variable regions of the antibody, and the sequences are constructed into an expression vector plasmid, so that a recombinant monoclonal antibody with stable and efficient expression is obtained. The recombinant antibody is used for virus titration of chimpanzee 68 type adenovirus and verification, and the specificity, linear range, repeatability, intermediate precision, and durability of the recombinant monoclonal antibody obtained by the application for detecting chimpanzee 68 type adenovirus all meet the requirements.
Owner:BRAVOVAX +1

Recombinant nucleic acid construct, recombinant vaccinia virus, vaccine composition and application thereof

The invention discloses a recombinant nucleic acid construct, a recombinant vaccinia virus, a vaccine composition and application thereof, and relates to the recombinant nucleic acid construct for preventing human adenovirus infection, the recombinant vaccinia virus prepared from the recombinant nucleic acid construct, the vaccine composition containing the virus, and preparation and application of the recombinant nucleic acid construct and the recombinant vaccinia virus. The technical problems that an existing multivalent vaccine is not uniform in immune effect and tedious in construction process are solved. The invention discloses a recombinant nucleic acid construct which comprises a vaccinia virus homologous recombination arm and an expression cassette unit located between the vaccinia virus homologous recombination arm. The expression cassette unit comprises human type-55, type-3 and type-7 adenovirus HEXON protein coding genes, the type-55 gene is reverse, and the type-3 and type-7 genes are forward. The recombinant vaccinia virus constructed by the method can realize stable co-expression of multivalent antigens, and is used for preparing multivalent vaccines for preventing infection of human type 3, type 7 and type 55 adenoviruses. The method is suitable for the fields of vaccine research and development, infectious disease prevention and control, viral vector technology platforms, recombinant protein or multivalent antigen expression technology and the like.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Monoclonal antibody aiming at canine adenovirus as well as application and kit thereof

The invention relates to the technical field of animal epidemic disease detection, in particular to a monoclonal antibody aiming at canine adenovirus as well as application and a kit thereof. According to the invention, the canine adenovirus HEXON protein is used as an immune source, two hybridoma cell strains FD-CAV-2F5 and FD-CAV-4D4 are constructed, and monoclonal antibodies secreted by the hybridoma cell strains have strong specific binding capacity with canine adenoviruses (including type 1 and type 2). The monoclonal antibody is used for constructing a test strip and a kit for detecting the canine adenovirus, and the test strip and the kit have the advantages of simplicity in operation, high specificity, high sensitivity, quick result and easiness in judgment, and can be used for quickly detecting the canine adenovirus.
Owner:SHENZHEN FENDER BIOTECHNOLOGY CO LTD

Anti-human adenovirus hexon protein antibody and application thereof

The invention relates to the technical field of biological medicine, and provides an anti-human adenovirus hexon protein antibody and application thereof. The antibody comprises a heavy chain variable region and a light chain variable region; wherein the heavy chain variable region comprises three heavy chain antigen complementary regions: the amino acid sequence is as shown in SEQ ID NO.10-12; the light chain variable region comprises three light chain antigen complementary regions: an LCDR1 with an amino acid sequence as shown in SEQ ID NO.13, an LCDR2 with an amino acid sequence as AAS and an LCDR3 with an amino acid sequence as shown in SEQ ID NO.14. Related experiments prove that the antibody can specifically recognize human type 55 adenovirus Hexon protein, the antigen epitope is an A180-A193 region, and infection of HAdV-55 virus and / or HAdV-11 virus can be effectively prevented and controlled.
Owner:NANJING MEDICAL UNIV